Dementia

See the Dementia Evidence Map for summaries of the available research on this topic.

Dementia is a clinical syndrome resulting from medical disease that causes abnormal brain changes. It is characterized by a progressive decline in memory and other cognitive domains that are severe enough to interfere with daily living and independent functioning. Dementia may result from a variety of medical diseases and may be due to more than one disease process. See the National Institutes of Health’s resource on understanding different types of dementia for further information.

This definition is consistent with the diagnostic category, major neurocognitive disorder (NCD), as defined in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; American Psychiatric Association [APA], 2013). The diagnostic criteria for major NCD are as follows:

  • There is a significant decline from previous levels of performance in one or more cognitive domains, including complex attention, executive function, learning and memory, language, perceptual motor, or social cognition (preferably documented by standardized testing or clinical assessment).
  • Cognitive deficits interfere with independence in everyday activities.
  • Cognitive deficits do not occur exclusively in the context of delirium.
  • Cognitive deficits are not better explained by other mental disorders, such as major depressive disorder or schizophrenia (APA, 2013).

The diagnosis of dementia is made by a medical team. Audiologists and speech-language pathologists (SLP) are important members of interprofessional teams that treat individuals with dementia and can provide vital information about cognitive-communication, language, and feeding/eating/swallowing skills that can contribute to appropriate diagnosis. See ASHA’s resource on interprofessional education/interprofessional practice (IPE/IPP).

Most dementias are associated with neuropathology that includes diffuse atrophy of cortical and subcortical structures; disruption of neural pathways; and the abnormal accumulation of amyloid beta, tau, and other proteins resulting in plaques and tangles (Schneider, 2022).

Cognitive and behavioral symptoms of dementia are differentiated from those associated with typical aging as well as from those associated with temporary or treatable conditions, including the following:

  • Delirium—an acute state of confusion associated with temporary, but reversible, cognitive impairments (Mahendra & Hopper, 2013).
  • Other conditions that have inconsistent symptoms or that are temporary and/or treatable, including
    • infections (e.g., urinary tract infection, meningitis, syphilis);
    • toxicity (e.g., drug-induced dementia, toxic metal exposure);
    • vitamin B12 deficiency;
    • metabolic disorders (e.g., kidney failure);
    • hormonal dysfunction (e.g., thyroid problems); and
    • pseudodementia due to psychiatric disorders (e.g., depression, generalized anxiety disorder, schizophrenia, mania, conversion disorders).

Unlike these conditions, the symptoms associated with dementia continue to progress in severity until death (see, e.g., Bourgeois & Hickey, 2009).

Cognitive changes caused by dementia may impact communication and may cause challenging behaviors (e.g., paranoia, hallucinations, and repetitiousness) and other responsive behaviors (atypical behaviors in response to stimuli that are perceived as stressors in the environment), such as wandering, restlessness, or calling out. SLPs can help caregivers determine the communication intent of these behaviors (Lanzi et al., 2021; Yous et al., 2019).

Mild Cognitive Impairment

Mild cognitive impairment (MCI), also known as mild neurocognitive disorder (mild NCD), is a clinical syndrome that is characterized by a modest decline in one or more cognitive domains. MCI is often referred to as an early stage of cognitive impairment that is in between typical aging and dementia; however, MCI does not always progress to dementia (Petersen et al., 2014). Early identification of MCI may enable the use of cognitive interventions to slow the progression of decline (Huckans et al., 2013; Qualls, 2005; Tsolaki et al., 2011). See the discussion on modifiable risk factors in the Risk Factors section of this Practice Portal page.

This definition of MCI is consistent with the diagnostic category, mild NCD, as defined in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; APA, 2013). The clinical criteria for diagnosing mild NCD are as follows:

  • There is a modest decline from previous levels of performance in one or more cognitive domains—including complex attention, executive function, learning and memory, language, perceptual motor, or social cognition (preferably documented by standardized testing or clinical assessment).
  • Cognitive deficits do not interfere with the ability to independently perform everyday activities (although some may require greater effort or use of compensatory strategies).
  • Cognitive deficits do not occur exclusively in the context of delirium.
  • Cognitive deficits are not better explained by other mental disorders, such as major depressive disorder or schizophrenia (APA, 2013).

See ASHA’s Mild Cognitive Impairment Evidence Map for summaries of the available evidence on this topic.

Early-Onset Dementia

Early-onset dementia, also known as “young-onset dementia,” refers to dementia that occurs before the age of 65 years. Differential diagnosis of early-onset dementia is complicated by the fact that symptoms may be more variable in younger patients than in elderly patients due to different etiologies (Fadil et al., 2009; Masellis et al., 2013; McMurtray et al., 2006; Rossor et al., 2010); lack of awareness about the condition, even among health care professionals (Jefferies & Agrawal, 2009); and misdiagnosis (van Vliet et al., 2011). Some causes of dementia symptoms could be reversible if detected early and the underlying medical conditions, such as infections and metabolic toxins, are treated. Therefore, early detection and accurate diagnosis are crucial (Fadil et al., 2009).

Content Disclaimer: The Practice Portal, ASHA policy documents, and guidelines contain information for use in all settings; however, members must consider all applicable local, state and federal requirements when applying the information in their specific work setting.

ASHA Corporate Partners